2021年翻译资格考试三级笔译练习题：中国自主研发心脏支架

2021年翻译资格考试三级笔译练习题：中国
自主研发心脏支架
所有的成功都来自于行动，只有付诸行动，才能一步步走向成功。

所以想要考证书的亲们，快去了解一下吧，以下为“2021翻译资格考试三级笔译练习题：
中国自主研发的心脏支架”，参考！更多相关讯息请关注WTT！
China’s Self-developed Heart Stent s Worldwide Recognition
A Chinese-made heart stent has won recognition from the international medal munity, with clinal trial results published online
in the prestious medal journal The Lancet.
Named Firehawk, the drug-eluting stent was developed by MroPort Scientif Corporation, a Chinese healthcare pany, to treat patients with coronary artery disease.
The metal stent is 86 mrons thk, whh is roughly the diameter of a human hair.
It contains drugs in mro grooves engraved by lasers on the surface, whh prevents the drug from leaking during the transportation of the stent.
Clinal trials were conducted in 21 hospitals in 10 European countries from December 20 to October 20.
Altogether 1,653 patients from the UK, France, Spain, Italy, Belum, the Netherlands, Poland, Germany, Austria, and Denmark were implanted with the stent.
According to William Wijns, a professor from the National
University of Ireland Galway who led the clinal study, this is the first
time that China’s medal deve went through randomized clinal trials in Europe on such a scale.
Results showed that the safety and clinal effacy of this stent could rival the ience stent, one of the world’s leading drug-eluting stents.
In addition, its unique design could save drug dosages and help prevent side effects such as thrombus after implantation.
中国自主研发的心脏支架赢得了全世界的认可
一种中国制造的心脏支架获得了国际医学界的认可，其临床试验结果发表在医学杂志《柳叶刀》的网站上。

这种药物洗脱支架被命名为Firehawk，由中国医疗保健公司MroPort Scientif Corporation开发，用于治疗冠心病患者。

这个金属支架有86微米厚，大概是人类头发的直径。

它包含药物在表面激光雕刻的微槽中，防止药物在运送支架时泄漏。

20年12月至20年10月在10个欧洲国家的21家医院进行临床试验。

共有1653名来自英国、法国、西班牙、意大利、比利时、荷兰、波兰、德国、奥地利和丹麦的患者植入了这种支架。

领导临床研究的爱尔兰戈尔韦国立大学教授威廉·魏恩斯表示，这是中国医疗设备首次在欧洲进行如此规模的随机临床试验。

结果表明，该支架的安全性和临床疗效可以与世界上的药物洗脱支架之一的先思支架相媲美。

此外，其独特的设计可以节省药物剂量，并有助于防止植入后血栓等副作用。